ERBB2 and cancer: Luminal A is characterized by high ER and PR and overexpression of the HER2 receptor and Ki67, which indicates slower cell growth, better prognosis, and better response to hormone therapy.While luminal B cancers are also HR-positive but can be either HER2+ or HER2−.